Black Hawk Acquisition Corp (BKHA) Financial Statements
Industry: Biological Products, (No Diagnostic Substances)
In fiscal 2025, Black Hawk Acquisition reported revenue of $0. Net income was $1.3M. Operating activities generated -$650,321 of cash. At fiscal year end, Black Hawk Acquisition held $23.9M in total assets against $3.9M in total liabilities, including $0 of cash and equivalents.
Open the full interactive Black Hawk Acquisition financials → Quarterly statements, key ratios, valuation history and price charts.
Black Hawk Acquisition Key Stats
| Share Price | $12.48 |
|---|---|
| Market Cap | $26.5M |
| 52-Week Range | $11.07 – $13.10 |
| Shares Outstanding | 2.1 million (basic, 2026 Q3) |
Black Hawk Acquisition Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Income | -$576,076 | -$915,510 |
| Pre-Tax Income | $1.9M | $1.3M |
| Net Income | $1.9M | $1.3M |
Black Hawk Acquisition Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$3,765 | $139,805 | $88,929 | $1.1M |
| Diluted EPS | — | $0.03 | $0.02 | $0.26 |
Black Hawk Acquisition Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash & Equivalents | $0 | $0 |
| Current Assets | $314,071 | $50,790 |
| Total Assets | $72.1M | $23.9M |
| Current Liabilities | $70,978 | $1.5M |
| Total Long-Term Debt | — | $250,000 |
| Total Liabilities | $2.5M | $3.9M |
| Shareholders' Equity | -$2.2M | -$3.8M |
Black Hawk Acquisition Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$553,665 | -$650,321 |
| Cash From Investing | -$69.3M | $50.3M |
| Cash From Financing | $70.0M | -$49.8M |
Figures from Black Hawk Acquisition's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Black Hawk Acquisition financials page for every line item.
Black Hawk Acquisition Company Profile
| Ticker | BKHA |
|---|---|
| Exchange | Nasdaq |
| Industry | Biological Products, (No Diagnostic Substances) |
| Headquarters | Danville, California |
| Fiscal Year End | November 30 |
| SEC Filer Category | Non-accelerated filer, smaller reporting company, emerging growth company |
| SEC CIK | 0002000775 |
Frequently Asked Questions
What was Black Hawk Acquisition's revenue in fiscal 2025?
Black Hawk Acquisition (BKHA) reported revenue of $0 for fiscal 2025.
What was Black Hawk Acquisition's net income in fiscal 2025?
Black Hawk Acquisition reported net income of $1.3M for fiscal 2025.
What was Black Hawk Acquisition's revenue last quarter?
In its most recent reported quarter (2026 Q3), Black Hawk Acquisition reported revenue of $0.
How much debt does Black Hawk Acquisition have?
Black Hawk Acquisition reported $250,000 of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Black Hawk Acquisition are outstanding?
Black Hawk Acquisition reported a weighted average of 2.1 million basic shares outstanding in 2026 Q3.
What is Black Hawk Acquisition's market cap?
Based on its latest closing price, Black Hawk Acquisition (BKHA) has a market capitalization of about $26.5M.
When does Black Hawk Acquisition's fiscal year end?
Black Hawk Acquisition's fiscal year end, as registered with the SEC, is November 30.
Where is Black Hawk Acquisition headquartered?
Black Hawk Acquisition lists its business address in Danville, California in its SEC filings.